American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

August 31, 2020

Newsletter Sponsor

Tamping Force on Bi-Layer Tablet Robustness

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or may be intended for delivery at different rates. As part of combining the layers in a multi-layer tablet, layers that precede a second or third layer must be lightly compressed or “tamped” before the successive layer is applied. The amount of tamping force applied has a direct effect on the strength of the bond created between the two layers. This paper analyzes the effect of varying the tamping force on the resulting bond between layers.

	Industry News

Hackensack Meridian Health Enrolling Individuals for COVID-19 Vaccine Clinical Trial
Hackensack Meridian Health is now enrolling individuals in a COVID-19 vaccine clinical trial. read more »

RedHill Biopharma Announces Positive Recommendation from COVID-19 Study
RedHill Biopharma announced its U.S. Phase 2 study with opaganib in patients hospitalized with ... read more »

Ridgeback Announces Initiation of Expanded Access Protocol for Ebola Treatment
Ridgeback announced the implementation of an expanded access protocol to ensure rapid access to its ... read more »

FDA Authorizes First Diagnostic Test Where Results Can Be Read Directly From Testing Card
The FDA has issued an emergency use authorization for the first antigen test where results can be ... read more »

OncoSec Announces Initiation of aStudy to Evaluate Melanoma Treatment
OncoSec Medical Incorporated announced the commencement of a study to evaluate its lead product ... read more »

FDA Works to Mitigate Shortages of Rifampin, Rifapentine Due to Nitrosamine Impurities
The FDA recently became aware of nitrosamine impurities in certain samples of rifampin and ... read more »

	Featured Articles

Orchestrating the Digital Cell and Gene Therapy Treatment Journey Around the Patient Life sciences companies supplying individualized cell and gene therapies (CGTs) will need to create ... read more »

Paving the Way for Real Time Process Monitoring in Biomanufacturing The typical manufacturing process for biopharmaceuticals includes a cell culture process that ... read more »

	Featured Announcements

A Successful Journey to Cell Therapy Manufacturing
Webinar
In this webinar, we will discuss three key areas to consider when you’re preparing to commercialize ... read more »

	Infographic

Advanced Features and Benefits of the Steritest™ NEO System
Sterility testing is one of the most crucial steps in pharmaceutical product release. read more »

	Featured Video

On-Demand Webinar: Platform Purification Approaches for the Production of Complex Biologics
In this webinar we will discuss the attributes of Thermo Scientific POROS Ion Exchange and Hydrophobic Interaction chromatography resins, addressing ... watch »

Watch Video: Introducing the SKANFOG SPECTRA
Watch Video: Introducing the SKANFOG SPECTRA watch »

	Featured Products

HT100 Tablet Testing System
read more »

BARETab TM PH
read more »

	Featured Whitepaper

Solutions to Today’s Biomanufacturing Challenges
With more complex molecules in development, changing capacity needs, uncertain forecasts and increased competition, the market demands flexibility and innovative approaches to address today’s new ... read more »

Objective characterization of liposomal drug delivery platforms: Using cryoTEM and designated image analysis software
Quality-critical attributes particular to liposome drug products include physicochemical properties such as particle size distribution and morphology, e.g. their overall shape. Such properties will ... read more »

	Events

Temperature Control and Logistics U.S. Online Summit
Virtual – 09/22/2020
The World’s Largest Life Science Temperature Controlled Supply Chain Summit, formerly known as Cold Chain Global Forum. This year, we're focusing ... event details »

BIO Investor Forum Digital
Virtual – 10/13/2020
BIO Investor Forum Digital will showcase drug development programs that are ready for partnering or venture funding and to accelerating the progress ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA